Anti-graft group says drugmakers failing to tackle corruption

LONDON, June 2 (Reuters) - The global pharmaceuticals industry remains open to corruption abuse, despite a raft of scandals in recent years, with both companies and governments failing to tackle the issue adequately, according to Transparency International.

http://news.trust.org/item/20160601230428-hnkzw